BROWN ADVISORY INC – Blueprint Medicines Corporation Transaction History
BROWN ADVISORY INC portfolio value:
$64.04M
portfolio value
BROWN ADVISORY INC quarter portfolio value change:
+30.45%
quarter
Blueprint Medicines Corporation 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -2.34% | -23.27K shares | 13.77M | $65.89 | 971.99K |
| Q2 2022 | share | Increase | +5.06% | 46.24K shares | -9.80M | $50.51 | 959.64K |
| Q1 2022 | share | Increase | +4.24% | 37.14K shares | -35.27M | $63.88 | 913.40K |
| Q4 2021 | share | Increase | +3.19% | 27.08K shares | 6.55M | $109.45 | 876.25K |
| Q3 2021 | share | Increase | +6.70% | 53.31K shares | 17.29M | $102.81 | 849.17K |
| Q2 2021 | share | Increase | +5.16% | 39.04K shares | -3.58M | $87.96 | 795.85K |
| Q1 2021 | share | Increase | +2.74% | 20.17K shares | -9.03M | $97.23 | 756.80K |
| Q4 2020 | share | Increase | +1.99% | 14.37K shares | 15.66M | $112.15 | 736.63K |
| Q3 2020 | share | Increase | +1.52% | 10.78K shares | 11.45M | $92.7 | 722.25K |
| Q2 2020 | share | Increase | +64.70% | 279.50K shares | 30.23M | $78 | 711.47K |
| Q1 2020 | share | Increase | +14.47% | 54.60K shares | -4.96M | $58.48 | 431.97K |
| Q4 2019 | share | Increase | +5.00% | 17.98K shares | 3.82M | $80.11 | 377.37K |
| Q3 2019 | share | Increase | +31.00% | 85.04K shares | 526K | $73.47 | 359.39K |
| Q2 2019 | share | Increase | +15.58% | 36.97K shares | 6.87M | $94.33 | 274.34K |
| Q1 2019 | share | Increase | 0.00% | 237.37K shares | 19.00M | $80.05 | 237.37K |